These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17462597)

  • 1. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells.
    Kim YG; Lee CK; Nah SS; Mun SH; Yoo B; Moon HB
    Biochem Biophys Res Commun; 2007 Jun; 357(4):1046-52. PubMed ID: 17462597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS; Krishnadas DK; Agrawal B
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treg cells suppress osteoclast formation: a new link between the immune system and bone.
    Zaiss MM; Axmann R; Zwerina J; Polzer K; Gückel E; Skapenko A; Schulze-Koops H; Horwood N; Cope A; Schett G
    Arthritis Rheum; 2007 Dec; 56(12):4104-12. PubMed ID: 18050211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells.
    Fu Y; Yi S; Wu J; Jimenez E; Simond D; Hawthorne WJ; O'Connell PJ
    Transplantation; 2008 Sep; 86(6):865-74. PubMed ID: 18813112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4-mediated functional activation of human CD4+CD25+ regulatory T cells.
    Becker C; Kubach J; Wijdenes J; Knop J; Jonuleit H
    Eur J Immunol; 2007 May; 37(5):1217-23. PubMed ID: 17407195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T-cells in periapical lesions.
    Colić M; Gazivoda D; Vucević D; Majstorović I; Vasilijić S; Rudolf R; Brkić Z; Milosavljević P
    J Dent Res; 2009 Nov; 88(11):997-1002. PubMed ID: 19828886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role of CD4+CD25+ T cells as well as transcription factor Foxp3 in the dysregulation of allergic rhinitis.
    Xu G; Mou Z; Jiang H; Cheng L; Shi J; Xu R; Oh Y; Li H
    Laryngoscope; 2007 May; 117(5):876-80. PubMed ID: 17473687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
    Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
    Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
    Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.
    Wu J; Yi S; Ouyang L; Jimenez E; Simond D; Wang W; Wang Y; Hawthorne WJ; O'Connell PJ
    Transplantation; 2008 Jun; 85(12):1841-8. PubMed ID: 18580479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
    Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
    Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
    Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
    Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation, flow cytometric analysis, and suppression assay of CD4+ CD25+ T-regulatory cells.
    Jeal H
    Methods Mol Med; 2008; 138():85-96. PubMed ID: 18615246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A; Noble A
    J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of high mobility group box-1 protein on the correlation between regulatory T cells and CD4+ CD25- T cells of spleen in mice].
    Zhang Y; Yao YM; Yu Y; Wu Y; Sheng ZY
    Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):217-20. PubMed ID: 18683721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
    Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL
    J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25- T cells through tumor-derived factors.
    Mao C; Wang S; Jiang Q; Tong J; Ma J; Yang M; Xu X; Qiu G; Shao Q; Li L; Xu H
    Onkologie; 2008 May; 31(5):243-8. PubMed ID: 18497513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.